z-logo
Premium
Korean medicinal plants inhibiting to Human Immunodeficiency Virus type 1 (HIV‐1) fusion
Author(s) -
Chang YoungSu,
Woo EunRhan
Publication year - 2003
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.1155
Subject(s) - syncytium , cell fusion , traditional medicine , glycoprotein , pharmacognosy , virus , human immunodeficiency virus (hiv) , bark (sound) , enfuvirtide , biology , virology , in vitro , chemistry , botany , biological activity , biochemistry , gp41 , medicine , cell , immunology , antibody , ecology , epitope
In order to nd novel anti‐HIV agents from natural products, 80 MeOH extracts of Korean plants were applied to a syncytia formation inhibition assay, which is based on the interaction between the HIV‐1 envelope glycoprotein gp120/41 and the cellular membrane protein CD4 of T lymphocytes. The most potent HIV‐1 fusion inhibition was shown by the stem bark of Ailanthus altissima with 74.9 ± 4.4% at a concentration of 100 µg/mL. Copyright © 2003 John Wiley & Sons, Ltd.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom